← FDA Drug Approvals (Drugs@FDA)
DEGEVMA
BLA · Biologics License Application · Sponsor: TEVA PHARMACEUTICALS, INC. · Approved 2026-09-25
Drug application
- FDA Application #
BLA761481- Application type
- Biologics License Application
- Brand name
- DEGEVMA
- Generic name
- Denosumab-Adet
- Active ingredients
- DENOSUMAB-ADET
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMACEUTICALS, INC.
- First approval
- 2026-09-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown